Otrivine Junior Sine Conservans Tegen Neusverstopping (Xylometazoline Hydrochloride)

Xylometazoline is an alpha‑adrenergic agonist. By stimulating α1‑receptors on the blood vessels of the nasal lining, it causes vasoconstriction, which decreases mucosal edema and opens the nasal passages, providing rapid decongestion.

The exact dose is determined by the prescribing healthcare professional based on the child’s age and severity of symptoms. The prescriber will provide specific instructions on the number of sprays per nostril and the maximum duration of treatment.

Safety data for Xylometazoline in pregnancy and lactation are limited. It should only be used if clearly needed and after consultation with a qualified healthcare provider, who will weigh potential benefits against any possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Otrivine Junior contains Xylometazoline, which has a rapid onset and a duration of action of about 8‑10 hours. Compared with phenylephrine, it often provides longer relief with fewer systemic effects, while oxymetazoline offers a similar profile but may have a slightly higher risk of rebound congestion if used beyond three days.

Store the nasal spray at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use and out of reach of children.

Tilt the child's head slightly forward, insert the spray tip into one nostril, and gently press the pump to deliver the prescribed number of sprays. Repeat in the other nostril if directed. Avoid blowing the nose immediately after administration to allow the medication to act.

Serious adverse events, although rare, include severe nosebleeds, allergic reactions such as rash, swelling or anaphylaxis, and nasal ulceration or perforation. If any of these occur, discontinue use immediately and seek medical attention.

The product should be avoided in children for whom it has not been prescribed, in individuals with known hypersensitivity to Xylometazoline or any excipients, and in patients with severe hypertension, coronary artery disease, or uncontrolled thyroid disorders unless a physician advises otherwise.